- Report
- January 2025
- 142 Pages
Asia Pacific
From €2958EUR$3,250USD£2,512GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3641EUR$4,000USD£3,092GBP
- Report
- October 2024
- 134 Pages
North America
From €3641EUR$4,000USD£3,092GBP
- Report
- June 2024
- 130 Pages
North America
From €3641EUR$4,000USD£3,092GBP
- Report
- July 2024
- 108 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- July 2024
- 112 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- June 2024
- 120 Pages
North America
From €3521EUR$3,869USD£2,991GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3521EUR$3,869USD£2,991GBP
- Report
- June 2024
- 140 Pages
Europe
From €3521EUR$3,869USD£2,991GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3521EUR$3,869USD£2,991GBP
- Report
- June 2021
- 123 Pages
Global
From €1180EUR$1,297USD£1,003GBP
- Report
- July 2020
- 269 Pages
Global
From €3183EUR$3,497USD£2,703GBP
- Report
- August 2019
- 264 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- February 2023
- 336 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- January 2023
- 270 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- September 2022
- 799 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- April 2019
- 850 Pages
Global
From €4095EUR$4,499USD£3,478GBP
- Report
- January 2024
- 270 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- December 2023
- 110 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- September 2023
- 170 Pages
Global
From €4368EUR$4,799USD£3,710GBP
The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.
Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field.
The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more
